China Coronavirus Cases Up Sharply As Pharma Rushes To Aid
Kaletra Finding Off-Label Use
Executive Summary
AbbVie’s HIV therapy Kaletra is now being used by the Chinese government to treat coronavirus-infected patients after a respiratory expert endorsed its use, while other pharma companies from Bayer to Innovent are showering support as China battles its worst virus outbreak since the SARS epidemic 17 years ago.
You may also be interested in...
China Approves More Drugs For Cancer, Rare Diseases
BeiGene's BTK inhibitor for leukemia/lymphoma and Sanofi/Genzyme's enzyme replacement therapy for MPS I among novel drugs newly approved in China.
As China Glorifies Traditional Medicines, Doubters See A Haunted Past
In a key step to prop up traditional Chinese medicines, Beijing has proposed a law that could potentially punish any vocal doubters. The move signals a familiar pattern as China resorts to using old approaches when facing a flurry of new challenges.
COVID And Beyond: China Urged To Address Chronic Disease, Improve Access
Facing the aftermath of coronavirus disruption and supply chain reorganization, executives of multinational drug firms in China say the government needs to do more to help address a flurry of issues laid bare by the public health crisis.
Need a specific report? 1000+ reports available
Buy Reports